Perceptive Advisors LLC Pmv Pharmaceuticals, Inc. Transaction History

Perceptive Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$14.86 - $23.55 $1.86 Million - $2.94 Million	-125,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$19.99 - $30.24 $3.53 Million - $5.34 Million	-176,714 Reduced 58.57%	125,000 $2.89 Million
Q3 2021 Nov 15, 2021	SELL	$26.84 - $36.58 $11.9 Million - $16.3 Million	-444,843 Reduced 59.59%	301,714 $8.99 Million
Q1 2021 May 17, 2021	SELL	$30.66 - $49.5 $4.26 Million - $6.88 Million	-138,999 Reduced 15.7%	746,557 $24.6 Million
Q4 2020 Feb 16, 2021	BUY	$31.86 - $61.51 $8.92 Million - $17.2 Million	280,000 Added 46.24%	885,556 $54.5 Million
Q3 2020 Nov 16, 2020	BUY	$35.5 - $38.0 $21.5 Million - $23 Million	605,556 New	605,556 $21.5 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.